+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Interleukin"

From
COSENTYX Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

COSENTYX Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
JAK Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

JAK Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
From
From
From
From
From
From
Autoimmune Monoclonal Antibody Market Report 2026 - Product Thumbnail Image

Autoimmune Monoclonal Antibody Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Systemic Juvenile Idiopathic Arthritis Market Report 2026 - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Psoriasis Treatment - Global Strategic Business Report - Product Thumbnail Image

Psoriasis Treatment - Global Strategic Business Report

  • Report
  • June 2026
  • 566 Pages
  • Global
From
From
Tocilizumab Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Tocilizumab Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
From
Monoclonal Antibodies - Competitive Landscape, 2026 - Product Thumbnail Image

Monoclonal Antibodies - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
From
From
Loading Indicator

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases. In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more